
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Pharmacol.
Sec. Gastrointestinal and Hepatic Pharmacology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1591086
This article is a correction to:
Cynaroside ameliorates TNBS-induced colitis by inhibiting intestinal epithelial cell apoptosis via the PI3K/AKT signalling pathway
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
A Corrigendum onCynaroside ameliorates TNBS-induced colitis by inhibiting intestinal epithelial cell apoptosis via the PI3K/AKT signalling pathwayby Huang, J., Li, J., Geng, Z., Yin, L., Niu, M., Li, Q., et al. (2024). Front. Pharmacol. 15: 1496068. doi: 10.3389/fphar.2024.1496068Error in Figure/TableIn the published article, there was an error in Figure 7L as published. These were two western bolt (WB) strips were misused (Markers: Cas3 and GAPDH) in Figure 7L. We also checked the original WB images provided in the supplemental materials and found no errors. These two incorrect strips in Figure 7L were misused from two strips in Figure 8G (Markers: Cas3 and GAPDH). The corrected Figure 7 appear below.The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: Crohn's disease, Cynaroside, IECs apoptosis, Colonic organoids, PI3K/AKT
Received: 10 Mar 2025; Accepted: 21 Mar 2025.
Copyright: © 2025 Li, Huang, Geng, Yin, Niu, Li, Liu, Cheng, Zhang, Xue, Wang, Wang, Zuo and Hu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jing Li, The first affiliated hospital of Bengbu medical university, Bengbu, China
Jianguo Hu, The first affiliated hospital of Bengbu medical university, Bengbu, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.